EndoQuest Robotics™ announces participation at the 34th Annual Piper Sandler Healthcare Conference

EndoQuest Robotics™ announces participation at the 34th Annual Piper Sandler Healthcare Conference

Company CEO Kurt Azarbarzin to provide an update on the development of the intraluminal surgical robotic system

HOUSTON, Texas, United States, November 22, 2022 /EINPresswire.com/ – EndoQuest robotsdeveloper of the world’s first flexible endoscopic robotic system that enables scar-free, minimally invasive surgery, today announced that Kurt AZARBAZEN, CEO, will provide an update on the development of the intraluminal surgery (ELS) system during the Piper Sandler Healthcare 34th Annual Conference. On November 29 – December 1, 2022, at Lotte Mansion New York, New York, NY 10022.

Details about EndoQuest Robotics Presentations:

Title: The Future of Robotic Surgery
Date and time: Thursday, December 1, 2022; 10:00 – 10:55 a.m. ET
Contributor: Kurt Azarbarzin, CEO – EndoQuest Robotics
Session: panel discussion

Title: EndoQuest Robotics Presentation
Date and time: December 1, 2022; 12:50 – 1:10 p.m. ET
Contributor: Kurt Azarbarzin, CEO – EndoQuest Robotics

Mr. Azarbarzin’s presentation will include an update to the company’s advanced flexible robotic platform that enables therapeutic endoscopists and surgeons to perform intraluminal surgeries through the in-body lumen, eliminating the need for external incisions that result in visible scarring. The EndoQuest Robotics Endoluminal Surgical System (ELS) combines the flexibility of traditional endoscopy with the advantages of conventional surgical techniques to enable minimally invasive procedures with enhanced control and precision. The proprietary endoscope is a flexible, steerable upper tube that can connect two surgical instruments and a flexible video endoscope to a surgical objective. With the enhanced capabilities of the ELS system, endoscopists and surgeons can access areas of the GI tract through a natural opening using traditional surgical techniques in locations not previously possible.

About EndoQuest Robotics, Inc.
EndoQuest Robotics has developed the Endoluminal Surgical System (ELS), the world’s first robotic endoluminal surgical system that enables therapeutic endoscopists and surgeons to perform minimally invasive upper and lower GI surgery through a transoral or transanal approach. The robotic platform combines the flexibility of an endoscope that can navigate the curvature of a patient’s anatomy with devices that allow the physician to use a traditional two-handed surgical technique. The ELS system has other potential applications in a range of surgeries including appendectomies and cholecystectomy that can be performed without external incisions. For additional information, visit www.endoquestrobotics.com.

The ELS system is under development, has not been approved by the US Food and Drug Administration and is not for commercial sale in the United States.

Chris Clicher
EndoQuest robots
+1 949-310-8271
chris.klecher@endoquestrobotics.com
Visit us on social media:
Twitter
linkedin


#EndoQuest #Robotics #announces #participation #34th #Annual #Piper #Sandler #Healthcare #Conference

Leave a Comment

Your email address will not be published. Required fields are marked *